Laminin inhibits A β40 fibril formation promoted by apolipoprotein E4 in vitro

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 171-175

  Monji, Akira ^a   Tashiro, Ken Ichiro ^b   Yoshida, Ichiro ^a   Hayashi, Yoshihito ^b   Tashiro, Nobutada ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Apolipoprotein E; Electron microscopy; Laminin; Thioflavine T fluorescence

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; LAMININ;

ALZHEIMER DISEASE; ARTICLE; CELL ULTRASTRUCTURE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; NEUROTOXICITY; NEUROTROPISM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FLUORESCENT DYES; FLUOROMETRY; HUMANS; LAMININ; MICE; MICROSCOPY, ELECTRON; NEUROFIBRILS; THIAZOLES;

EID: 0032526536     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00342-4     Document Type: Article

References (25)

1. Bronfman F.C., Garrido J., Alvarez A., Morgan C., Inestrosa N.C. Laminin inhibits amyloid-β-peptide fibrillation. Neurosci. Lett. 218:1996;201-203.
2. Busciglio J., Lorenzo A., Yeh J., Yanker B.A. β-Amyloid fibrils induce tau phosphorylation and microtubule binding. Neuron. 14:1995;879-888.
3. Castano E.M., Prelli F., Wisniewski T., Golabek A., Kumar R.A., Soto C., Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306:1995;599-604.
4. Eikelenboom P., Zhan S.S., Kamphorst W., van der Valk P., Rozemuller J.M. Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Archiv. 424:1994;421-427.
5. Ghanta J., Shen C.-L., Kiessling L.L., Murphy R.M. A strategy for designing inhibitors β-amyloid toxicity. J. Biol. Chem. 271:1996;29525-29528.
6. Golabek A., Soto C., Vogel T., Wisniewski T. The interaction between apolipoprotein E and Alzheimer's amyloid β-peptide is dependent on β-peptide conformation. J. Biol. Chem. 271:1996;10602-10606.
7. Haass C. Presenilins: genes for life and death. Neuron. 18:1997;687-690.
8. Huang D.Y., Weisgraber K.H., Strittmatter W.J., Matthew W.D. Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Exp. Neurol. 136:1995;251-257.
9. Ishii K., Tamaoka A., Mizusawa H., Shoji H., Ohtake T., Fraser P.E., Takahashi H., Tuji S., Gearing M., Mizutani T., Yamada S., Kato M., St-George-Hyslop P.H., Mirra S.S., Mori H. Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E ε4 allele dosage in sporadic Alzheimer's disease. Brain Res. 748:1997;250-252.
10. Jarret J.T., Lansbury P.T. Seeding 'one-dimensional crystallization' of amyloid: a pathogenetic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
11. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;76-83.
12. Lorenzo A., Yanker B. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
13. Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain Res. Rev. 23:1997;1-27.
14. Ma J., Yee A., Brewer H.B. Jr., Das S., Potter H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
15. Masliah E., Mallory M., Veinbergs I., Miller A., Samuel W. Alterations in apolipoprotein E expression during aging and neurodegeneration. Prog. Neurobiol. 50:1996;493-503.
16. Murtomaki S., Risteri J., Risteri L., Koivisto U.M., Johansson S., Liesi P. Laminin and its neurite outgrowth-promoting domain in the brain of Alzheimer's disease and Down's syndrome patients. Neurosci. J. Res. 32:1992;261-273.
17. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
18. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
19. Salomon A.R., Marcinowski K.J., Friedland R.P., Zagorski M.G. Nicotine inhibits amyloid formation by the β-peptide. Biochemistry. 35:1996;13568-13578.
20. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
21. Soto C., Castano E.M. The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem. J. 314:1996;701-707.
22. Soto C., Kindy M.S., Baumann M., Frangione B. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun. 226:1996;672-680.
23. Timpl R., Brown C.J. The laminins. Matrix Biol. 14:1994;275-281.
24. Wisniewski T., Castano E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1994;1030-1035.
25. Yanker B.A. Mechanism of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.